May 27, 2022

Regeneron Pharmaceuticals, Inc. v. Amgen Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. March 30, 2023

    Off Beat: Funding, Face-Offs & Food Fights

    A Texas federal judge who does significant patent work will be stepping down, drug companies sparring over patents at the U.S. Supreme Court found themselves again going toe-to-toe over a different area of law, California judges provided trial tips throughout March, and the integrity of popular snacks was brought into question in Illinois. Here's what intellectual property attorneys should know about these issues and others outside their practice.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!